BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19802733)

  • 1. Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma.
    Urakawa H; Nishida Y; Nakashima H; Shimoyama Y; Nakamura S; Ishiguro N
    Clin Exp Metastasis; 2009; 26(8):1005-12. PubMed ID: 19802733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
    Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
    Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
    Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
    Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
    Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
    Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
    Front Immunol; 2018; 9():724. PubMed ID: 29719533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.
    Seppälä M; Halme E; Tiilikainen L; Luukkainen A; Laranne J; Rautiainen M; Huhtala H; Paavonen T; Toppila-Salmi S
    Acta Otolaryngol; 2016 Jul; 136(7):729-35. PubMed ID: 26982018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
    Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
    Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
    Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
    Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.
    Kaya M; Aksoy A; Artas G; Kaplan M
    Ideggyogy Sz; 2023 Sep; 76(9-10):339-347. PubMed ID: 37782060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.
    Mangaonkar A; Mondal AK; Fulzule S; Pundkar C; Park EJ; Jillella A; Kota V; Xu H; Savage NM; Shi H; Munn D; Kolhe R
    Sci Rep; 2017 Oct; 7(1):12892. PubMed ID: 29038460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
    Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
    Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
    Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
    Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.